Asterias Biotherapeutics, Inc. — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d615aa53-0b5b-4619-a744-02aa0afa6125/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2017 | $-28.4M | 2017-01-01 – 2017-12-31 | evidence 0001140361-18-013695 |
| FY 2016 | $-35.5M | 2016-01-01 – 2016-12-31 | evidence 0001140361-17-013626 |
| FY 2015 | $-15.0M | 2015-01-01 – 2015-12-31 | evidence 0001140361-16-059357 |
| FY 2014 | $-33.2M | 2012-09-24 – 2014-12-31 | evidence 0001140361-15-011245 |
| FY 2013 | $-25.4M | 2012-09-24 – 2014-03-31 | evidence 0001140361-14-020013 |
| FY 2012 | $-758.9k | 2012-01-01 – 2012-12-31 | evidence 0001140361-14-013049 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Asterias Biotherapeutics, Inc. — all facts · Revenue · Operating Income